Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension study - 24/04/13
Amy Paller, MD, Children’s Memorial Hospital and Northwestern University Medical School, Chicago, IL, United States; David Pariser, MD, Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research, Norfolk, VA, United States; Elaine Siegfried, MD, Cardinal Glennon Children’s Hospital and Saint Louis University, Saint Louis, MO, United States; Gregory Kricorian, MD, Amgen, Thousand Oaks, CA, United States
Le texte complet de cet article est disponible en PDF. Commercial support: Funded by Immunex Corp, a wholly owned subsidiary of Amgen, and by Wyeth. |
Vol 62 - N° 3S1
P. AB11 - mars 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?